Quick Answer
Journey Medical Corp reported Revenue From Contract With Customer Excluding Assessed Tax of $61.24 million for the year ending 2025.
- Journey Medical Corp showed an increase of +11.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Journey Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $9.45 million | Q1 2021: $10.72 million | Q2 2021: $15.29 million | Q3 2021: $19.61 million | Q1 2022: $20.80 million | Q2 2022: $18.24 million | Q3 2022: $16.04 million | Q1 2023: $12.17 million | Q2 2023: $16.96 million | Q3 2023: $15.28 million | Q1 2024: $13.03 million | Q2 2024: $14.86 million | Q3 2024: $14.63 million | Q1 2025: $13.14 million | Q2 2025: $15.01 million | Q3 2025: $17.03 million.
- Over the full 6 years of available data (2020 to 2025), Journey Medical Corp's Revenue From Contract With Customer Excluding Assessed Tax has grown by 37.5%.
- Historical annual values: Fiscal year 2025: $61.24 million | Fiscal year 2024: $55.13 million | Fiscal year 2023: $59.66 million | Fiscal year 2022: $71.00 million | Fiscal year 2021: $63.13 million | Fiscal year 2020: $44.53 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: